# A Study of DER 45-EV Gel to Treat Rosacea

> **NCT00940992** · PHASE2 · COMPLETED · sponsor: **Sol-Gel Technologies, Ltd.** · enrollment: 92 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** DER 45 EV
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT00940992
- **Lead sponsor:** Sol-Gel Technologies, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-09
- **Final completion:** 2013-01
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2015-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00940992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00940992, "A Study of DER 45-EV Gel to Treat Rosacea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00940992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*